Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 4
1946 8
1947 12
1948 9
1949 4
1951 35
1952 61
1953 55
1954 46
1955 48
1956 66
1957 76
1958 54
1959 79
1960 83
1961 101
1962 57
1963 3
1964 11
1965 121
1966 355
1967 395
1968 556
1969 728
1970 679
1971 770
1972 860
1973 915
1974 948
1975 920
1976 933
1977 965
1978 1049
1979 1165
1980 1131
1981 1020
1982 1145
1983 1179
1984 1286
1985 1312
1986 1479
1987 1527
1988 1717
1989 1957
1990 2119
1991 2373
1992 2503
1993 2693
1994 2863
1995 3082
1996 3282
1997 3445
1998 3823
1999 4154
2000 4512
2001 4719
2002 5069
2003 5964
2004 6472
2005 6819
2006 7499
2007 7699
2008 8448
2009 9143
2010 8870
2011 8844
2012 9245
2013 9463
2014 9251
2015 9169
2016 8346
2017 7796
2018 7478
2019 3061
2020 58
Text availability
Article attribute
Article type
Publication date

Search Results

190,717 results
Results by year
Filters applied: . Clear all
Page 1
Direct oral anticoagulants and cardiovascular prevention in patients with nonvalvular atrial fibrillation.
Marín F, et al. Expert Opin Pharmacother 2017 - Review. PMID 27924633
Expert opinion: The management of patients with atrial fibrillation should not be limited to the prevention of stroke, but should also include the prevention of cardiovascular events. Despite treatment with vitamin K antagonists, many patients with atrial fibrillation still develop cardiovascular complications, particularly individuals whose anticoagulation is difficult to control. ...
Expert opinion: The management of patients with atrial fibrillation should not be limited to the prevention of stroke, but should als …
Usefulness of the Polypill for the Prevention of Cardiovascular Disease and Hypertension.
Chrysant SG and Chrysant GS. Curr Hypertens Rep 2016 - Review. PMID 26781254
Cardiovascular disease (CVD) remains the leading cause of death in the developed countries and is estimated to be the leading cause of death in the developing countries by the year 2030. ...This polypill has now been tested in several recent studies for the primary and secondary prevention of CVD and stroke with fairly good results. ...
Cardiovascular disease (CVD) remains the leading cause of death in the developed countries and is estimated to be the leading cause o
Secondary prevention of major cerebrovascular events with seven different statins: a multi-treatment meta-analysis.
Zhong P, et al. Drug Des Devel Ther 2017 - Review. PMID 28919704 Free PMC article.
BACKGROUND: Statins have been recommended for the use in atherosclerotic cardiovascular diseases, but different statins have distinct pharmacological characteristics. ...In the secondary prevention of cardiovascular diseases, the major CVEs in pravastatin (risk ratio [RR] 0.87, 0.76-0.99)- and atorvastatin (RR 0.59, 0.49-0.72)-treated patients reduced significantly compared with controls. ...
BACKGROUND: Statins have been recommended for the use in atherosclerotic cardiovascular diseases, but different statins have d …
[Presentation]
Saia F. G Ital Cardiol (Rome) 2019. PMID 30855025 Italian.
Cardiovascular prevention and blood pressure reduction: a quantitative overview updated until 1 March 2003.
Staessen JA, et al. J Hypertens 2003. PMID 12777939
Larger reductions in systolic pressure (weighted mean 1.8 mmHg) in two trials accounted for the advantage of AR1 blockers over conventional therapy in the prevention of stroke. ...The finding that blood pressure differences largely accounted for cardiovascular outcome emphasizes the desirability of tight blood pressure control. ...
Larger reductions in systolic pressure (weighted mean 1.8 mmHg) in two trials accounted for the advantage of AR1 blockers over conventional …
Optimal Running Dose and Cardiovascular Risk.
McMullen CW, et al. Curr Sports Med Rep 2018 - Review. PMID 29889148
The cardiovascular benefits of regular exercise are well established. A mortality benefit has clearly been demonstrated for those that participate in light and moderate exercise. ...Prevention and screening remain as key to lowering morbidity and mortality in all individuals....
The cardiovascular benefits of regular exercise are well established. A mortality benefit has clearly been demonstrated for those tha …
Prevention of cardiovascular diseases. Coronary artery disease, congestive heart failure, and stroke.
Messinger-Rapport BJ and Sprecher D. Clin Geriatr Med 2002 - Review. PMID 12424868
This article reviews evidence for cardiovascular risk factors and disease prevention in older adults. Interventions which reduce morbidity and mortality from coronary artery disease, heart failure, and cerebrovascular disease in the elderly population are examined. Attention is given to the role of cardiovascular disease in older women and in minorities, subsets not well-represented in many studies....
This article reviews evidence for cardiovascular risk factors and disease prevention in older adults. Interventions which redu …
[Cardiovascular prevention: current progress and the long road to travel].
Marrugat J, et al. Rev Esp Cardiol 2010. PMID 20540900 Spanish. Free article.
Also included are discussions of existing opportunities for improving current strategies for screening and cardiovascular prevention, of the value of measuring new biomarkers in individual patients, including genetic predisposition to coronary heart disease, and of some of the clinical measures used in practice, such as the ankle-brachial index and the carotid intima-media thickness. In addition, the most important subgroups of individuals at a high cardiovascular risk, as judged by their size and the number of cardiovascular events experienced at 10 years, are described. ...
Also included are discussions of existing opportunities for improving current strategies for screening and cardiovascular preventi
Cardiovascular prevention in the cancer survivor.
Chen CL. Curr Atheroscler Rep 2015 - Review. PMID 25637040
Cancer survivors may also have fewer typical symptoms of cardiovascular disease. Increased surveillance and aggressive control of cardiovascular disease is important in cancer patients both while undergoing active treatment and in the long term. ...This review is not intended to be a comprehensive review of all cancer therapy toxicity, but will focus on recent literature regarding prevention of CHF and coronary artery disease (CAD) during active cancer therapy as well as current screening guidelines for long-term survivors....
Cancer survivors may also have fewer typical symptoms of cardiovascular disease. Increased surveillance and aggressive control
Alternative prevention and treatment of cardiovascular disease, part 2.
Pratt C. Prim Care 2010 - Review. PMID 20493340
This article discusses alternative therapies for secondary prevention and treatment of major cardiac disorders: congestive heart failure, hypertension, dyslipidemias, and peripheral vascular disease. ...
This article discusses alternative therapies for secondary prevention and treatment of major cardiac disorders: congestive heart fail …
190,717 results
Jump to page
Feedback